The world of cryonics is a fascinating and often controversial topic, and a recent survey has shed light on the differing opinions of medical professionals, particularly neurosurgeons, regarding the plausibility of life extension through cryonic preservation. This survey, conducted by neuroscientist Ariel Zeleznikow-Johnston, reveals a stark contrast in perspectives among various medical specialties, with neurosurgeons expressing a notably more optimistic outlook than their colleagues in other fields.
The survey, which included over 300 physicians from diverse medical backgrounds, aimed to gauge their beliefs about the potential for cryonic preservation to lead to patient revival. While only 27.9% of the surveyed doctors deemed cryonic preservation plausible, the numbers took an intriguing turn when analyzed by specialty. Neurosurgeons, in particular, displayed a remarkable level of confidence in the procedure, estimating a 72% median probability of success for preserving critical psychological information through whole brain preservation and revival.
This optimism among neurosurgeons can be attributed to several factors. Firstly, their familiarity with the scientific basis of modern preservation methods may play a significant role. Zeleznikow-Johnston suggests that doctors who have interacted with dying patients and contemplated the possibilities of cryonics tend to be more open-minded. This firsthand experience likely shapes their perspective and fosters a more positive outlook on the procedure's potential.
The survey also explored doctors' opinions on various critical treatment issues related to cryonic preservation. One such issue is the administration of anticoagulants like heparin, which helps prevent blood clots that could impede revival. A substantial majority of physicians (70.7%) approved of this practice, recognizing its potential to enhance preservation success. This finding highlights the importance of anticoagulant therapy in the context of cryonics.
Additionally, the survey addressed the legal complexities surrounding cryonic preservation procedures. The majority of respondents (44.3%) believed that such procedures should be legal, indicating a growing acceptance of cryonics as a potential end-of-life option. However, a significant portion (28.8%) still opposed these procedures, underscoring the ongoing debate and the need for further discussion and education within the medical community.
It's worth noting that the survey's authors have a vested interest in cryonics, with Zeleznikow-Johnston's affiliation with the Brain Preservation Foundation and his colleagues' involvement in similar organizations. Despite this potential bias, the researchers emphasize that the relatively low probability estimate of revival success among all respondents suggests that their work remains unbiased and objective.
In conclusion, this survey provides valuable insights into the diverse opinions of medical professionals regarding cryonic preservation. The optimism expressed by neurosurgeons highlights the importance of scientific understanding and firsthand experience in shaping medical perspectives. As the field of cryonics continues to evolve, further research and dialogue are essential to address the ethical, legal, and scientific challenges associated with this extraordinary pursuit of life extension.
